Method of producing recombinant high molecular weight vWF in cell culture

US10100099B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10100099-B2
Application numberUS-201715591022-A
CountryUS
Kind codeB2
Filing dateMay 9, 2017
Priority dateJul 8, 2010
Publication dateOct 16, 2018
Grant dateOct 16, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Among other aspects, the present invention relates to cell culture conditions for producing high molecular weight vWF, in particular, highly multimericWF with a high specific activity and ADAMTS13 with a high specific activity. The cell culture conditions of the present invention can include, for example, a cell culture medium with an increased copper concentration and/or cell culture supernatant with a low ammonium (NH 4 + ) concentration. The present invention also provides methods for cultivating cells in the cell culture conditions to express high molecular weight vWF and rA13 having high specific activities.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for producing a recombinant ADAMTS13 (rA13) composition, the method comprising: culturing one or more mammalian cells comprising a nucleic acid encoding a rA13 protein in a cell culture media containing from 1 μg/L to 6 μg/L copper, such that rA13 is expressed and excreted from the mammalian cells into a culture supernatant; and recovering at least a portion of the culture supernatant, wherein the cell density is maintained at less than 4.0×10 6 cells per mL during the step of culturing the one or more mammalian cells; and wherein at least 1500 Units FRETS-VWF73 activity per liter cell culture media per day is present in the recovered culture supernatant. 2. The method of claim 1 , wherein the cell culture media is a protein free culture media. 3. The method of claim 1 , wherein the cell culture media is a chemically defined culture media. 4. The method of claim 1 , wherein the cell culture media contains from 2.0 μg/L to 4.0 μg/L copper. 5. The method of claim 1 , wherein the cell culture media contains 4 μg/L copper. 6. The method of claim 1 , wherein the cell culture media contains 2 μg/L copper. 7. The method of claim 1 , wherein the mammalian cells are CHO cells. 8. The method of claim 4 , wherein the mammalian cells are CHO cells. 9. The method of claim 5 , wherein the mammalian cells are CHO cells. 10. The method of claim 6 , wherein the mammalian cells are CHO cells. 11. The method of claim 1 , wherein culturing the one or more mammalian cells comprises continuous cultivation of the mammalian cells. 12. The method of claim 11 , wherein the continuous cultivation of mammalian cells is performed in chemostatic mode. 13. The method of claim 11 , wherein the continuous cultivation of mammalian cells is performed in perfusion mode. 14. The method of claim 1 , wherein the one or more mammalian cells is cultured in at least 100 L of the cell culture media. 15. The method of claim 1 , wherein the cell density is maintained at between 2.0×10 6 cells per mL and 4.0×10 6 per mL during the step of culturing the one or more mammalian cells. 16. The method of claim 4 , wherein the cell density is maintained at between 2.0×10 6 cells per mL and 4.0×10 6 per mL during the step of culturing the one or more mammalian cells. 17. The method of claim 1 , wherein the cell culture media contains from 5 mg/L to 10 mg/L nicotinamide. 18. The method of claim 4 , wherein the cell culture media contains from 5 mg/L to 10 mg/L nicotinamide. 19. The method of claim 15 , wherein the cell culture media contains from 5 mg/L to 10 mg/L nicotinamide. 20. The method of claim 1 , wherein the cell culture media contains about 7 mg/L nicotinamide. 21. The method of claim 4 , wherein the cell culture media contains about 7 mg/L nicotinamide. 22. The method of claim 5 , wherein the cell culture media contains about 7 mg/L nicotinamide. 23. The method of claim 6 , wherein the cell culture media contains about 7 mg/L nicotinamide.

Assignees

Inventors

Classifications

  • ADAMTS13 endopeptidase (3.4.24.87) · CPC title

  • Preparation of peptides or proteins (single cell protein C12N1/00) · CPC title

  • Cells for large scale production · CPC title

  • Proteins not provided for elsewhere · CPC title

  • Iron; Fe chelators; Transferrin · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10100099B2 cover?
Among other aspects, the present invention relates to cell culture conditions for producing high molecular weight vWF, in particular, highly multimericWF with a high specific activity and ADAMTS13 with a high specific activity. The cell culture conditions of the present invention can include, for example, a cell culture medium with an increased copper concentration and/or cell culture supernata…
Who is the assignee on this patent?
Baxalta Inc, Baxalta GmbH
What technology area does this patent fall under?
Primary CPC classification C12N5/0018. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).